Medical Communications

Showing 15 posts of 6411 posts found.

Recipharm to end operations in two facilities in Sweden

November 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm today announces that it will initiate a process with the intention of discontinuing manufacturing operations at its facilities in …
skin-222664_960_720

Gene therapy helps child regrow 80% of skin

November 9, 2017 Medical Communications, Research and Development biotech, drugs, gene therapy, pharma, pharmaceutical, stem cell

A young child has been brought back from the verge of death after an experimental combination of stem cell and …
simon-stevens

NHS Chief in high-stakes gambit to boost funding in autumn budget

November 9, 2017 Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

It speaks to the desperation of the funding crisis for the NHS that Chief Executive of the NHS, Simon Stevens, …
gsk_wall

GSK indicates a return to oncology by appointing Roche veteran

November 9, 2017 Medical Communications GSK, Hal Barron, biotech, drugs, pharma, pharmaceutical

GSK, under its new CEO, has made most of its waves recently not with approvals but with high-profile appointments, and …
promotional_banner

The End Game: Payer Engagement Webinar

November 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical

In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …
cellectis

Cellectis given another shot at off-the-shelf CAR-T

November 8, 2017 Medical Communications, Research and Development CAR-T, biotech, cellectis, drugs, pharma, pharmaceutical

It is easy to forget the very real dangers that CAR-T treatment present to patients after Novartis and Gilead both …
doctor_notes

Clinical trials still have a problem with ethnic minorities

November 8, 2017 Medical Communications, Research and Development biotech, clinical trials, drugs, ethnic minorities, pharma, pharmaceutical

Research, published in the Journal of Women’s Health, that aimed to determine the effects of the FDA’s guidance on the …
window-2387518_960_720

Clinical trial transparency: Letting the light in

November 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, clinical trial transparency, clinical trials, drugs, pharma, pharmaceutical

Transparency is one of those words for which the exact meaning has become clouded by murkier connotations. The chances are …
smartphone-1957740_960_720

NHS to offer GP appointments via smartphone

November 6, 2017 Medical Communications, Sales and Marketing GP at hand, NHS, biotech, drugs, pharma, pharmaceutical

It has been announced that I trial will begin in London offering the public GP consultations through their smartphone. The …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug, pharma, pharmaceuticals, top ten

As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …
dr-patrick-vallance-gsk

GSK’s R&D head to move on after shift in focus

November 3, 2017 Medical Communications GSK, biotech, drugs, pharma, pharmaceutical

There has been a raft of changes at senior levels of GSK since Emma Walmsley took over the role from …
andrew_witty_gsk_new

Witty to lead way in fast-tracking medicine through UK system

November 3, 2017 Medical Communications AAR, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical

The UK government has announced its response to the Accelerated Access Review that was published last year, with former GSK …
gsk_boronia_australia

GSK’s experimental multiple myeloma scores Breakthrough designation with FDA

November 3, 2017 Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, GSK, GlaxoSmithKline, multiple myeloma, pharma

GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a monotherapy in …

Teva’s woes continue, as shares sink to 17-year low on Q3 results

November 2, 2017 Medical Communications Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Spare a thought for Kare Schultz, he agreed to take on the position of CEO at Teva at the start …
The Gateway to Local Adoption Series

Latest content